Toinv - It is my impression that there are a couple of LOI's that are dependant on something(who knows what) and that one or more of these LOI's would/could have cash attached to them if that something happens. If that cash that RM2 speculated on came to fruition then a smaller overall dilution would be required. Of course we don't know what that something is or if it is even attainable. I can understand why DM is taking this stepped in approach as if one or more of these LOI's do work out there will be less shares to spread the wealth with. Always keep in mind that DM has more than 4 million shares so dilution affects him bigger than most of us.

I was really hoping we would hear in the news release the other day that the first person in the US was recruited and how many clinics would be recruiting. That didn't happen. It sounds like there is only around 100 patients left to be recruited to reach the 2400 mark.

BDAZ could you please repost your estimate and formula for the event count you came up with in Apr/May last year. If it is taking this long to get 188 3 point MACE events I'm starting to think this could be very good for us. Frustrating as heck, but good for us. Is it red or white wine that goes with crow? I'm bringing the wine.

The admission you refer to in the Isreal deal; DM was able to deals with Eastern and Hepalink with a lot less information than what they know today. I'm willing to let this one play out before making any harsh judgement on this deal. I believe there is something afoot here that will see the double digit royalties they referred to be very different than the arrangement with Zenith. This thought is total speculation on my part. If I am correct in my speculation we could end up seeing sales in a number jurisdictions prior to EMA/FDA approval.

As far as a TSX delisting goes I thought we had past that hurdle when the $87 million financing was completed and was quite surprised to see it even mentioned in the news release the other day.

DM has stated on a number of occasions that all of the reporting requirements for a NASDAQ listing are up to date. Not at the most recent AGM but in a couple prior to Dec 2017. The share price doesn't seem to be and hasn't been up to where it needs to be for a listing on the regular board so we are where we are.

If the science is as good as what it could be there will be a whole bunch of people scratching their heads saying I remember hearing about that. If the science falls short of our expectations there will be a whole bunch of us scratching our heads saying what just hit me. It's going to happen this year boys and girls. Strap yourself in for a wild ride or jump off the roller coaster now. There is only 10 and a half months left in the year. Will you or the company last that long?

All IMO, DYODD

tada